Skip to main content

What type of drug is Steglatro?

Medically reviewed by Drugs.com. Last updated on Feb 16, 2024.

Official answer

by Drugs.com

Steglatro (ertugliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor.

This drug is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose), which is then eliminated in the urine and lowers blood sugar.

Read next

Related medical questions

Drug information

Related support groups